A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 11,856 shares of MRK stock, worth $1.33 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
11,856
Previous 11,559 2.57%
Holding current value
$1.33 Million
Previous $1.53 Million 3.8%
% of portfolio
0.6%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$123.8 - $132.96 $36,768 - $39,489
297 Added 2.57%
11,856 $1.47 Million
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $6,001 - $6,993
53 Added 0.46%
11,559 $1.53 Million
Q4 2023

Feb 01, 2024

BUY
$100.18 - $109.02 $5,509 - $5,996
55 Added 0.48%
11,506 $1.25 Million
Q3 2023

Oct 13, 2023

BUY
$102.95 - $114.33 $5,250 - $5,830
51 Added 0.45%
11,451 $1.18 Million
Q2 2023

Aug 01, 2023

BUY
$108.61 - $118.38 $5,539 - $6,037
51 Added 0.45%
11,400 $1.32 Million
Q1 2023

May 02, 2023

BUY
$102.94 - $114.86 $10,294 - $11,486
100 Added 0.89%
11,349 $1.21 Million
Q4 2022

Jan 26, 2023

BUY
$87.44 - $112.11 $5,158 - $6,614
59 Added 0.53%
11,249 $0
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $4,733 - $5,317
56 Added 0.5%
11,190 $964,000
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $8,098 - $9,180
97 Added 0.88%
11,134 $1.02 Million
Q1 2022

Apr 28, 2022

BUY
$73.51 - $82.4 $5,292 - $5,932
72 Added 0.66%
11,037 $906,000
Q4 2021

Jan 24, 2022

BUY
$72.28 - $90.54 $4,481 - $5,613
62 Added 0.57%
10,965 $840,000
Q3 2021

Oct 13, 2021

BUY
$71.68 - $78.83 $4,372 - $4,808
61 Added 0.56%
10,903 $819,000
Q2 2021

Jul 15, 2021

BUY
$70.31 - $77.77 $4,921 - $5,443
70 Added 0.65%
10,842 $843,000
Q1 2021

Apr 22, 2021

BUY
$68.86 - $81.11 $36,495 - $42,988
530 Added 5.17%
10,772 $830,000
Q4 2020

Mar 03, 2021

BUY
$71.77 - $79.65 $4,162 - $4,619
58 Added 0.57%
10,242 $838,000
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $4,390 - $4,977
60 Added 0.59%
10,184 $845,000
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $4,295 - $4,887
61 Added 0.61%
10,124 $783,000
Q1 2020

May 12, 2020

BUY
$63.36 - $87.82 $3,231 - $4,478
51 Added 0.51%
10,063 $774,000
Q4 2019

Feb 05, 2020

BUY
$77.58 - $87.54 $11,714 - $13,218
151 Added 1.53%
10,012 $911,000
Q3 2019

Nov 20, 2019

BUY
$76.08 - $82.93 $3,727 - $4,063
49 Added 0.5%
9,861 $830,000
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $3,422 - $3,997
49 Added 0.5%
9,812 $823,000
Q1 2019

May 07, 2019

BUY
$69.58 - $79.36 $2,365 - $2,698
34 Added 0.35%
9,763 $812,000
Q4 2018

Jan 23, 2019

BUY
$65.24 - $75.71 $16,701 - $19,381
256 Added 2.7%
9,729 $743,000
Q3 2018

Nov 15, 2018

BUY
$57.69 - $67.84 $4,211 - $4,952
73 Added 0.78%
9,473 $672,000
Q2 2018

Aug 02, 2018

SELL
$50.83 - $59.72 $16,723 - $19,647
-329 Reduced 3.38%
9,400 $571,000
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $21,148 - $24,580
-415 Reduced 4.09%
9,729 $530,000
Q4 2017

Feb 01, 2018

SELL
$51.62 - $61.64 $11,098 - $13,252
-215 Reduced 2.08%
10,144 $571,000
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $62,659 - $67,422
1,068 Added 11.49%
10,359 $663,000
Q2 2017

Aug 10, 2017

BUY
N/A
9,291
9,291 $595,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Jackson, Grant Investment Advisers, Inc. Portfolio

Follow Jackson, Grant Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson, Grant Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jackson, Grant Investment Advisers, Inc. with notifications on news.